FY2025 Annual Report

Reporting period: 2025.01.01-2025.12.31

Summary: DIAGENS-B (02526) reported Revenue of 164.42M(+133.72%); Operating profit of -66.58M(-201.22%); Net profit attributable to owners of -67.14M(-54.78%).

ReportedYoY
Prior YearYoY
RevenueUp YoY
164.42M133.72%
70.35M33.13%
Operating profitDown YoY
-66.58M201.22%
-22.10M44.55%
Net profit attributable to ownersDown YoY
-67.14M54.78%
-43.38M22.70%

Revenue

ReportedUnit: CNY

Operating profit

ReportedUnit: CNY

Net profit attributable to owners

ReportedUnit: CNY

Financial data: HKEXnews annual and interim reports; pre-listing years from the prospectus. YoY for ratios is the change in percentage points; ROE and ROA use annual reports only.

About this page

This page shows DIAGENS-B (02526) historical financial statements and corporate actions. Financial data comes from public financial disclosures in HKEX display documents, grouped by reporting period; corporate actions come from HKEXnews announcements.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect